Sort
25,944 grants matching “neurodegeneration”
Plasma brain-derived tau: a novel Alzheimerâs disease-type neurodegeneration biomarker with potential to complete the AT(N) scheme in blood
$5,693,957Thomas K Karikari · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · AG
Dominantly Inherited Alzheimer Network
$5,643,579Randall J Bateman · Washington University · U19 · FY2023 · AG
Sphingolipid Biology of Neurodegeneration
$5,572,752Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2025 · DK
Frontotemporal Dementia: Genes, Images, and Emotions
$5,553,559Maria Luisa Gorno Tempini · University Of California, San Francisco · P01 · FY2023 · AG
Roles of Gray Matter Brain Aging and Small Vessel Disease in AD Pathophysiology
$5,546,075Howard J Aizenstein · University Of Pittsburgh At Pittsburgh · RF1 · FY2021 · AG
Phase 2 Randomized, Double-Blind, Placebo-Controlled Clinical Trial of T3D-959 in Mild to Moderate Alzheimer's Disease Subjects
$5,526,538John Didsbury · T3d Therapeutics, Inc. · R01 · FY2022 · AG
Frontotemporal Dementia: Genes, Images, and Emotions
$5,506,891Maria Luisa Gorno Tempini · University Of California, San Francisco · P01 · FY2025 · AG
Frontotemporal Dementia: Genes, Images, and Emotions
$5,446,505Maria Luisa Gorno Tempini · University Of California, San Francisco · P01 · FY2024 · AG
Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis
$5,409,374Randall J Bateman · Washington University · R01 · FY2025 · AG
FDA approved IND 29644: Multicenter Phase 1 Trial to Evaluate Safety and Immunogenicity of Preventive Tau Vaccine, AV-1980R/A, in cognitively unimpaired preclinical AD participants.
$5,308,961Michael G Agadjanyan · Institute For Molecular Medicine · R01 · FY2025 · AG
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old
$5,224,302Rachel A Whitmer · University Of California At Davis · R01 · FY2024 · AG
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old
$5,187,231Rachel A Whitmer · University Of California At Davis · R01 · FY2023 · AG
Blood amyloid, tau, and neurodegeneration biomarkers and prediction of clinical onset, cognitive decline, and dementia diagnosis
$5,175,354Randall J Bateman · Washington University · R01 · FY2024 · AG
Genetic and epigenetic regulation of retinal development, aging and evolution
$5,173,977Anand Swaroop · National Eye Institute · ZIA · FY2022 · EY
The Neighborhoods Study: Contextual Disadvantage and Alzheimerâs Disease and Related Dementias (ADRD)
$5,172,719Amy J. Kind · University Of Wisconsin-Madison · R01 · FY2025 · AG
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in a Multiethnic Cohort of Oldest-Old
$5,163,761Rachel A Whitmer · University Of California At Davis · R01 · FY2022 · AG
Biological predictors of brain aging trajectories
$5,127,088Joel H Kramer · University Of California, San Francisco · RF1 · FY2020 · AG
ANTI-AMYLOID TREATMENT IN ASYMPTOMATIC ALZHEIMERS DISEASE
$5,116,455Reisa A. Sperling · University Of California, San Diego · U19 · FY2014 · AG
Epidemiology of Age-related Dementia, Mild Cognitive Impairment and Brain Pathology in Cohort of Oldest-Old
$5,105,538Rachel A Whitmer · University Of California At Davis · R01 · FY2025 · AG
Mechanisms of inherited neurodegenerative diseases
$5,084,626Michael Ward · National Institute Of Neurological Disorders And Stroke · ZIA · FY2025 · NS
Multimodal MRI in Multiple Sclerosis
$5,061,016Daniel Reich · National Institute Of Neurological Disorders And Stroke · ZIA · FY2021 · NS
NDC for the Optical Control of Biological Function
$5,039,000Ehud Isacoff · University Of California Berkeley · PN2 · FY2010 · EY
APOE in the Predisposition to, Protection from and Prevention of Alzheimer's Disease
$5,031,927Eric M Reiman · Banner Health · R01 · FY2023 · AG
Clinical & biological signatures of post-traumatic neurodegeneration: Leveraging the TBI Model Systems of Care to accelerate in vivo diagnosis of the late effects of TBI (LETBI)
$5,005,696Kristen Dams-O'Connor · Icahn School Of Medicine At Mount Sinai · RF1 · FY2022 · NS
NDC for the Optical Control of Biological Function
$5,000,000Ehud Isacoff · University Of California Berkeley · PN2 · FY2012 · EY